Search Results - "Cohen‐Ezra, Oranit"

Refine Results
  1. 1

    Immunogenicity and Adverse Effects of the 2‐Dose BNT162b2 Messenger RNA Vaccine Among Liver Transplantation Recipients by Davidov, Yana, Tsaraf, Keren, CohenEzra, Oranit, Likhter, Mariya, Ben Yakov, Gil, Levy, Itzchak, Levin, Einav G., Lustig, Yaniv, Mor, Orna, Rahav, Galia, Ben Ari, Ziv

    Published in Liver transplantation (01-02-2022)
    “…The BNT162b2 messenger RNA (mRNA) vaccine against severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has been shown to be safe and effective in…”
    Get full text
    Journal Article
  2. 2

    Alterations in the Gut Microbiome in the Progression of Cirrhosis to Hepatocellular Carcinoma by Lapidot, Yelena, Amir, Amnon, Nosenko, Rita, Uzan-Yulzari, Atara, Veitsman, Ella, Cohen-Ezra, Oranit, Davidov, Yana, Weiss, Peretz, Bradichevski, Tanya, Segev, Shlomo, Koren, Omry, Safran, Michal, Ben-Ari, Ziv

    Published in mSystems (16-06-2020)
    “…Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related mortality worldwide. While cirrhosis is the main risk factor for HCC, the factors…”
    Get full text
    Journal Article
  3. 3

    Positive antimitochondrial antibody but normal serum alkaline phosphatase levels: Could it be primary biliary cholangitis? by Berdichevski, Tania, CohenEzra, Oranit, Pappo, Orit, Ben‐Ari, Ziv

    Published in Hepatology research (01-07-2017)
    “…Aim Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease, typically diagnosed by elevated cholestatic liver enzymes and a positive…”
    Get full text
    Journal Article
  4. 4

    Research trends analysis of chronic hepatitis C versus nonalcoholic fatty liver disease: A literature review text‐mining analysis of publications by Klang, Eyal, Soffer, Shelly, Alper, Lee, Shimon, Orit, Barash, Yiftach, Davidov, Yana, Likhter, Mariya, CohenEzra, Oranit, Ben Yakov, Gil, Ben‐Ari, Ziv

    Published in Health science reports (01-11-2022)
    “…Background Hepatits C virus (HCV) rates have lowered due to direct‐acting antiviral treatment. Nonalcoholic steatohepatitis (NASH)/nonalcoholic fatty liver…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    Ombitasvir/paritaprevir/ritonavir & dasabuvir ± ribavirin following protease inhibitors failure - a prospective multi-centre trial by Deutsch, Liat, Houri, Inbal, Ben-Ari, Ziv, Shlomai, Amir, Veitsman, Ella, Cohen-Ezra, Oranit, Issachar, Assaf, Mor, Orna, Gozlan, Yael, Bruck, Rafael, Menachem, Yoram, Zelber-Sagi, Shira, Katchman, Helena, Shibolet, Oren

    Published in BMC infectious diseases (03-04-2020)
    “…Hepatitis C virus (HCV) infection is a leading cause of chronic liver disease and hepatocellular carcinoma. Treatment with first generation protease inhibitors…”
    Get full text
    Journal Article
  10. 10

    HBV-RNA, Quantitative HBsAg, Levels of HBV in Peripheral Lymphocytes and HBV Mutation Profiles in Chronic Hepatitis B by Gozlan, Yael, Aaron, Daniella, Davidov, Yana, Likhter, Maria, Ben Yakov, Gil, Cohen-Ezra, Oranit, Picard, Orit, Erster, Oran, Mendelson, Ella, Ben-Ari, Ziv, Abu Baker, Fadi, Mor, Orna

    Published in Viruses (11-03-2022)
    “…A comprehensive characterization of chronic HBV (CHB) patients is required to guide therapeutic decisions. The cumulative impact of classical and novel…”
    Get full text
    Journal Article
  11. 11

    Prevalence of hepatitis E virus antibodies, Israel, 2009-2010 by Mor, Orna, Bassal, Ravit, Michaeli, Michal, Wax, Marina, Ram, Daniela, Cohen-Ezra, Oranit, Cohen, Dani, Mendelson, Ella, Ben-Ari, Ziv, Shohat, Tamy

    Published in Emerging infectious diseases (01-04-2015)
    “…We investigated prevalence of hepatitis E virus in a sample of the population of Israel. The overall seroprevalence of antibodies to the virus was 10.6% (95%…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Secondary sclerosing cholangitis following major burn by Ben-Ari, Ziv, Levingston, David, Weitzman, Ella, Haviv-Yadid, Yael, Cohen-Ezra, Oranit, Weiss, Peretz, Zuckerman, Eli, Inbar, Yael, Amitai, Michal, Rimon, Uri, Goder, Maya, Haik, Josef

    Published in Annals of hepatology (01-09-2015)
    “…AbstractBackground and aims. Secondary sclerosing cholangitis in critically ill patients (SSC-CIP) is a relatively new previously unrecognized entity which may…”
    Get full text
    Journal Article
  14. 14

    Ciliated hepatic foregut cyst with high intra-cystic carbohydrate antigen 19-9 level by Ben Ari, Ziv, Cohen-Ezra, Oranit, Weidenfeld, Jonathan, Bradichevsky, Tania, Weitzman, Ella, Rimon, Uri, Inbar, Yael, Amitai, Michal, Bar-Zachai, Barak, Eshkenazy, Roni, Ariche, Arie, Azoulay, Daniel

    Published in World journal of gastroenterology : WJG (21-11-2014)
    “…A ciliated hepatic foregut cyst(CHFC)is a rare foregut developmental malformation usually diagnosed in adulthood.Five percent of reported cases of CHFC…”
    Get full text
    Journal Article
  15. 15

    Alterations in the Gut Microbiome in the Progression of Cirrhosis to Hepatocellular Carcinoma by Lapidot, Yelena, Amir, Amnon, Nosenko, Rita, Uzan-Yulzari, Atara, Veitsman, Ella, Cohen-Ezra, Oranit, Davidov, Yana, Weiss, Peretz, Bradichevski, Tanya, Segev, Shlomo, Koren, Omry, Safran, Michal, Ben-Ari, Ziv

    Published in mSystems (16-06-2020)
    “…Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related mortality worldwide. While cirrhosis is the main risk factor for HCC, the factors…”
    Get full text
    Journal Article
  16. 16

    A third dose of the BNT162b2 mRNA vaccine significantly improves immune responses among liver transplant recipients by Davidov, Yana, Indenbaum, Victoria, Tsaraf, Keren, Cohen-Ezra, Oranit, Likhter, Mariya, Ben Yakov, Gil, Halperin, Rebecca, Levy, Itzchak, Mor, Orna, Agmon-Levin, Nancy, Afek, Arnon, Rahav, Galia, Lustig, Yaniv, Ben Ari, Ziv

    Published in Journal of hepatology (01-09-2022)
    “…Immune responses of solid organ transplant recipients to 2 doses of the BNT162b2 mRNA anti-SARS-CoV-2 vaccine are impaired. The immunogenicity and safety of a…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    Atezolizumab and bevacizumab in advanced hepatocellular carcinoma: Real-world data by Bezalel, Nomi, Davidov, Yana, Likhter, Mariya, Cohen Ezra, Oranit, Inbar, Yael, Halpern, Naama, Boursi, Ben, Beller, Tamar, Pery, Ron, Shmueli, Einat S, Nachmany, Ido, Ben Ari, Ziv, Margalit, Ofer

    Published in Journal of clinical oncology (01-06-2023)
    “…e16167 Background: Treatment of advanced unresectable hepatocellular carcinoma (HCC) has advanced substantially in the past few years with the use of…”
    Get full text
    Journal Article
  20. 20